Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Thursday
June 30, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
THURSDAY, JUNE 30, 2022
Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial

Coronavirus chronicle

Reuters
25 February, 2021, 05:45 pm
Last modified: 25 February, 2021, 05:48 pm

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Week-long booster dose inoculation starts in June
  • Pfizer eyes Covid vaccine for all variants before 2023
  • Pfizer-BioNTech seek US approval of second Covid booster for 65+
  • Bangladesh receives 10m more Pfizer doses from US 

Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial

The companies believe their current two-dose vaccine will work against the South African variant as well as one found in the United Kingdom and elsewhere

Reuters
25 February, 2021, 05:45 pm
Last modified: 25 February, 2021, 05:48 pm
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

Pfizer Inc and BioNTech SE said on Thursday they are testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus.

They are also in talks with regulatory authorities about testing a vaccine modified to protect specifically against the highly transmissible new variant found in South Africa and elsewhere, known as B.1.351, as a second arm of the same study.

The companies believe their current two-dose vaccine will work against the South African variant as well as one found in the United Kingdom and elsewhere. But the studies will allow the vaccine makers to be prepared if and when more protection is necessary, they said.

"The rate of mutations in the current virus is higher than expected," Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.

"It's a reasonable probability that we would end up with regular boosts. And for potent vaccines, it may be that you need to do a strain change every few years, but not necessarily every year."

In the first stage of the first arm of the study, a third 30 microgram dose will be given to as many as 144 people who received the vaccine 6 to 12 months ago in the original Phase I safety trial.

Assuming regulatory approval, a redesigned vaccine would also be tested, both as a booster dose in people who have been vaccinated and in people who had not yet received the vaccine, Dolsten said.

The trial would not seek to measure the efficacy of the vaccine like their large Phase III trial last year. Instead it would measure the antibody response and study whether blood from recipients can neutralize the new coronavirus variants, as well as the safety of a third dose.

The United States discovered its first case of the South African variant in January and it has since turned up in 14 states, according to US government data. Several studies suggest it is more resistant to existing vaccines than other variants of the coronavirus.

Pfizer's Dolsten said that mRNA vaccines like Pfizer and BioNTech's create a potent response. But the immune response may wane over time.

He believes that a third dose of their vaccine will create a similar or better response than the second dose, and could be the logical next step for staying ahead of circulating variants.

"We think our vaccine is robustly active against all strains," Dolsten said, noting that the companies "want to be prepared for all options and be data driven - led by science."

Dolsten said the new trial would likely be predominantly conducted in the United States.

Moderna Inc said on Wednesday it is also working with US government scientists to study an experimental booster shot that targets the variant first found in South Africa.

Top News

Pfizer Covid-19 Vaccine / Booster Shot

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image
    Some amnesty for offshore assets kept, corporate taxes cut
  • RnB artist R Kelly. Photo: Getty Images via BBC
    US Artist R Kelly sentenced to 30 years on sexual abuse charges
  • Saudi Arabia to celebrate Eid-ul-Adha on 9 July
    Saudi Arabia to celebrate Eid-ul-Adha on 9 July

MOST VIEWED

  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?
  • People line up at a nucleic acid testing station, following the coronavirus disease (COVID-19) outbreak, in Beijing, China, June 16, 2022. REUTERS/Thomas Peter/File Photo
    China slashes Covid quarantine time for international travellers
  • Covid-19 deaths were reported from Gorakhpur, Jalaun, Bulandshahr, Kannauj, Sonbhadra, Gonda, Bhadohi, Basti, Kushinagar and Mau (HT Photo)
    India sees 45% jump in a day with 17,073 new Covid cases

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Week-long booster dose inoculation starts in June
  • Pfizer eyes Covid vaccine for all variants before 2023
  • Pfizer-BioNTech seek US approval of second Covid booster for 65+
  • Bangladesh receives 10m more Pfizer doses from US 

Features

Mahathir accused financial titans of seeking to reverse decades of economic development that propelled tens of millions into the middle class. Photo: Bloomberg

George Soros, Mahathir and the legacy of 1997

16h | Panorama
 If Bangladesh produces and exports high-value-added MMF products right now, we can increase our total export by around 25% in value. Photo: Mumit M

Time ripe for Bangladesh RMG sector to focus more on man-made fibres

20h | Panorama
Human Library Bangladesh has organised so far nine sessions; eight have been held in different parts of Dhaka and one in Khulna. Photo: Courtesy

Human Library Bangladesh: Where the halls come alive with human voices

21h | Panorama
Abortion is a part of healthcare. Photo: Bloomberg

Abortion is healthcare and women’s rights are human rights

1d | Panorama

More Videos from TBS

Severodonetsk now under Russian control

Severodonetsk now under Russian control

9h | Videos
South African boy drove ambition, says Elon's father

South African boy drove ambition, says Elon's father

9h | Videos
Why Dollar crisis will last long?

Why Dollar crisis will last long?

9h | Videos
Beautiful mural at Padma bridge

Beautiful mural at Padma bridge

13h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
An aerial view of a MRT Line-6 construction site. Work on the first elevated metro rail of Bangladesh is going on in full swing. A total of 16 elevated stations will connect the capital’s Uttara to Motijheel via Mirpur, Farmgate and Dhaka University. The photo was taken from Farmgate area recently. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net